Create mode – the default mode when you create a requisition and PunchOut to Bio-Rad. You can create and edit multiple shopping carts
Edit mode – allows you to edit or modify an existing requisition (prior to submitting). You will be able to modify only the cart that you have PunchedOut to, and won't have access to any other carts
Inspect mode – when you PunchOut to Bio-Rad from a previously created requisition but without initiating an Edit session, you will be in this mode. You cannot modify any Cart contents
Bio-Rad-Antibodies.com relies on third-party cookies to show you pricing, allow you to order online, and connect you to My Bio-Rad. Please amend your browser settings to enable third-party cookies and access this website’s full functionality.
Click here to find out how
Protocol: PK Bridging ELISA Detecting Total Drug Using Anti-Tocilizumab Antibodies
Pharmacokinetic (PK) Bridging ELISA detects total drug (free and partially bound): For Use with Anti-Tocilizumab Monoclonal Antibodies HCA252 and HCA257P
This method provides a procedure for carrying out a PK ELISA with Anti-Tocilizumab Antibodies HCA252 (capture antibody) and HCA257P (detection antibody), and using tocilizumab for the standard curve.
Anti-Tocilizumab Antibody HCA252 is an inhibitory antibody. Anti-Tocilizumab Antibody HCA257P is a non-inhibitory antibody that does not inhibit the binding of tocilizumab to its target Interleukin 6 Receptor (IL-6R). This combination enables measurement of free and partially bound tocilizumab, which is equivalent to total drug when trough serum levels are above 10 µg/ml. The method should always be used in conjunction with product and batch specific information provided with each vial (see product datasheets). This protocol will need to be adjusted for use with different detection methods and immunoassay technology platforms.
View all of our tocilizumab antibodies